Literature DB >> 20851689

Depression in epilepsy: why aren't we treating?

Sheri Cotterman-Hart1.   

Abstract

Depression is a common and largely untreated comorbidity in patients with epilepsy. Our aim was to examine physician attitudes that may contribute to this treatment gap. We surveyed primary care physicians, neurologists, and psychiatrists chosen from the Ohio State Medical Board registry on the topics of depression in epilepsy, seizures with antidepressant use, and comfort in treating depression in epilepsy. Our data identified fear of increased seizure frequency with antidepressant use as a significant barrier to treatment. There was a clear inverse relationship between the estimated risk of antidepressant-induced seizures and comfort treating depression in epilepsy (P = 0.02), with 52% of primary care physicians identifying this as a reason for not treating depression in this population. Further education of community physicians and neurologists regarding the importance of treating depression in patients with epilepsy and research into the use of antidepressants in this population are indicated.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851689     DOI: 10.1016/j.yebeh.2010.08.018

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  13 in total

Review 1.  A Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders.

Authors:  Surabhi Thapliyal; Tanveer Singh; Shailendra Handu; Manisha Bisht; Puja Kumari; Priyanka Arya; Pallavi Srivastava; Ravi Gandham
Journal:  Neurochem Res       Date:  2021-02-05       Impact factor: 3.996

Review 2.  Depression in epilepsy: a critical review from a clinical perspective.

Authors:  Christian Hoppe; Christian E Elger
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

Review 3.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

4.  Creatine attenuates seizure severity, anxiety and depressive-like behaviors in pentylenetetrazole kindled mice.

Authors:  Emmanuel O Okwuofu; Gbenga E Ogundepo; Abigail M Akhigbemen; Akinpelu L Abiola; Raymond I Ozolua; Ighodaro Igbe; Ononiwu Chinazamoku
Journal:  Metab Brain Dis       Date:  2021-02-09       Impact factor: 3.584

Review 5.  Depressive syndromes in neurological disorders.

Authors:  Julian Hellmann-Regen; Dominique Piber; Kim Hinkelmann; Stefan M Gold; Christoph Heesen; Carsten Spitzer; Matthias Endres; Christian Otte
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11       Impact factor: 5.270

Review 6.  Antidepressants for people with epilepsy and depression.

Authors:  Melissa J Maguire; Jennifer Weston; Jasvinder Singh; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2014-12-03

Review 7.  Suicide and Epilepsy.

Authors:  Luciana Giambarberi; Heidi M Munger Clary
Journal:  Curr Neurol Neurosci Rep       Date:  2022-06-17       Impact factor: 6.030

Review 8.  [Depression and neurological diseases].

Authors:  D Piber; K Hinkelmann; S M Gold; C Heesen; C Spitzer; M Endres; C Otte
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

9.  A primary healthcare screening tool to identify depression and anxiety disorders among people with epilepsy in Zambia.

Authors:  Edward K Mbewe; Leana R Uys; Ntombifikile M Nkwanyana; Gretchen L Birbeck
Journal:  Epilepsy Behav       Date:  2013-03-17       Impact factor: 2.937

10.  Antidepressants for people with epilepsy and depression.

Authors:  Melissa J Maguire; Anthony G Marson; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2021-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.